Stellarex Drug-Coated Balloon for Treatment of Femoropopliteal Disease: 12-Month Outcomes from the Randomized ILLUMENATE Pivotal and Pharmacokinetic Studies.
about
Drug-Coated Balloon vs Standard Percutaneous Transluminal Angioplasty for the Treatment of Atherosclerotic Lesions in the Superficial Femoral and Proximal Popliteal Arteries: One-Year Results of the MDT-2113 SFA Japan Randomized Trial.Stellarex drug-coated balloon for treatment of femoropopliteal arterial disease-The ILLUMENATE Global Study: 12-Month results from a prospective, multicenter, single-arm study.Comparison of treatment strategies for femoro-popliteal disease: A network meta-analysis.
P2860
Stellarex Drug-Coated Balloon for Treatment of Femoropopliteal Disease: 12-Month Outcomes from the Randomized ILLUMENATE Pivotal and Pharmacokinetic Studies.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Stellarex Drug-Coated Balloon ...... l and Pharmacokinetic Studies.
@en
type
label
Stellarex Drug-Coated Balloon ...... l and Pharmacokinetic Studies.
@en
prefLabel
Stellarex Drug-Coated Balloon ...... l and Pharmacokinetic Studies.
@en
P2093
P2860
P1433
P1476
Stellarex Drug-Coated Balloon ...... l and Pharmacokinetic Studies.
@en
P2093
Andrew H Holden
Carlos Mena-Hurtado
J A Mustapha
Joseph Cardenas
Khusrow Niazi
Marianne Brodmann
Martin Werner
Michael R Jaff
Peter Faries
P2860
P304
P356
10.1161/CIRCULATIONAHA.117.028893
P407
P577
2017-07-20T00:00:00Z